{"organizations": [], "uuid": "e7aec19d476102d657643888c4b46fef4c37ab13", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?m=02&d=20180410&t=2&i=1249786238&w=1200&r=LYNXMPEE3900O", "site_section": "http://feeds.reuters.com/reuters/UKBusinessNews/", "section_title": "Reuters: Business News", "url": "https://uk.reuters.com/article/uk-samsung-bioepis-stocks-samsung-c-t-co/samsung-ct-shares-rise-after-report-of-planned-stake-purchase-in-biopharma-affiliate-idUKKBN1HH01J", "country": "US", "domain_rank": 408, "title": "Samsung C&T shares rise after report of planned stake purchase in biopharma affiliate", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-10T03:23:00.000+03:00", "replies_count": 0, "uuid": "e7aec19d476102d657643888c4b46fef4c37ab13"}, "author": "", "url": "https://uk.reuters.com/article/uk-samsung-bioepis-stocks-samsung-c-t-co/samsung-ct-shares-rise-after-report-of-planned-stake-purchase-in-biopharma-affiliate-idUKKBN1HH01J", "ord_in_thread": 0, "title": "Samsung C&T shares rise after report of planned stake purchase in biopharma affiliate", "locations": [], "entities": {"persons": [{"name": "stephen coates", "sentiment": "none"}, {"name": "joyce lee", "sentiment": "none"}], "locations": [{"name": "south korea", "sentiment": "none"}, {"name": "seoul", "sentiment": "none"}, {"name": "seoul", "sentiment": "none"}], "organizations": [{"name": "samsung c&t", "sentiment": "negative"}, {"name": "samsung c&t corp", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "south korean tv", "sentiment": "none"}, {"name": "samsung bioepis co ltd", "sentiment": "none"}, {"name": "samsung biologics co ltd", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "samsung", "sentiment": "none"}, {"name": "samsung bioepis", "sentiment": "none"}, {"name": "mbc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 10, 2018 / 12:24 AM / Updated an hour ago Samsung C&T shares rise after report of planned stake purchase in biopharma affiliate Reuters Staff 1 Min Read \nSEOUL (Reuters) - Shares in Samsung C&T Corp rose 3.6 percent on Tuesday after a report said the company is considering raising up to 3 trillion won (1.98 billion pounds) to buy a 30 percent stake in biopharma affiliate Samsung Bioepis Co Ltd. FILE PHOTO: Employees walk past a logo of Samsung C&T Corp at the company's headquarters in Seoul, South Korea, July 16, 2015. REUTERS/Kim Hong-Ji \nSamsung C&T has been contacting large financial institutions to raise the money, South Korean TV channel MBC reported on Monday, citing an unnamed person with knowledge of Samsungâ€™s process. \nAnother affiliate, Samsung BioLogics Co Ltd, which owned 94.6 percent of Samsung Bioepis as of end-2017, saw its shares rise 6.8 percent in early trade. Reporting by Joyce Lee; Editing by Stephen Coates", "external_links": [], "published": "2018-04-10T03:23:00.000+03:00", "crawled": "2018-04-10T04:14:32.009+03:00", "highlightTitle": ""}